Literature DB >> 9070861

Expression and cloning of the human X-linked hypophosphatemia gene cDNA.

M Grieff1, S Mumm, P Waeltz, R Mazzarella, M P Whyte, R V Thakker, D Schlessinger.   

Abstract

X-linked hypophosphatemia (XLH), which is a heritable metabolic bone disease characterized biochemically by selective renal phosphate (Pi) wasting, is associated with mutations in the PEX (Phosphate-regulating gene with homologies to Endopeptidases on the X-chromosome) gene. To further explore the physiologic role of PEX and define its effect in XLH we have determined the expression and tissue distribution. Northern analysis found abundant PEX mRNA in a restricted pattern, predominantly in adult ovary and fetal lung. In addition, PEX expression was also found in adult lung and fetal liver. A PEX cDNA of 2550 basepairs, which contains the full PEX coding region, was isolated from a human ovary cDNA library. The PEX cDNA shows high homology to other membrane-bound zinc metallopeptidases. The presence of PEX in nonosseous tissues strongly suggests features of a systemic role, rather than a unique function in bone development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070861     DOI: 10.1006/bbrc.1997.6153

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Hypophosphatemic rickets.

Authors:  L A DiMeglio; M J Econs
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

Review 2.  The molecular background to hypophosphataemic rickets.

Authors:  P S Rowe
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

3.  Human recombinant endopeptidase PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein.

Authors:  Marcelo Campos; Constance Couture; Izaura Y Hirata; Maria A Juliano; Thomas P Loisel; Philippe Crine; Luiz Juliano; Guy Boileau; Adriana K Carmona
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

4.  MRNA expression of Phex in mice and rats: the effect of low phosphate diet.

Authors:  M H Meyer; R A Meyer
Journal:  Endocrine       Date:  2000-08       Impact factor: 3.633

5.  A de novo mosaic mutation of PHEX in a boy with hypophosphatemic rickets.

Authors:  Chen Weng; Jiao Chen; Li Sun; Zhong-Wei Zhou; Xue Feng; Jun-Hui Sun; Ling-Ping Lu; Ping Yu; Ming Qi
Journal:  J Hum Genet       Date:  2015-11-12       Impact factor: 3.172

Review 6.  FGF23, Hypophosphatemia, and Emerging Treatments.

Authors:  Erik A Imel; Andrew Biggin; Aaron Schindeler; Craig F Munns
Journal:  JBMR Plus       Date:  2019-05-13

7.  PHEXL222P Mutation Increases Phex Expression in a New ENU Mouse Model for XLH Disease.

Authors:  Carole El Hakam; Alexis Parenté; Fabienne Baraige; Laetitia Magnol; Lionel Forestier; Florent Di Meo; Véronique Blanquet
Journal:  Genes (Basel)       Date:  2022-07-28       Impact factor: 4.141

8.  PHEX gene mutations and genotype-phenotype analysis of Korean patients with hypophosphatemic rickets.

Authors:  Hae Ryong Song; Joo Won Park; Dae Yeon Cho; Jae Hyuk Yang; Hye Ran Yoon; Sung Chul Jung
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

9.  A Novel PHEX Gene Mutation in a Patient with Sporadic Hypophosphatemic Rickets.

Authors:  Yea Eun Kang; Jun Hwa Hong; Jimin Kim; Kyong Hye Joung; Hyun Jin Kim; Bon Jeong Ku; Koon Soon Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2014-06-26

Review 10.  Clinical Evidence for the Benefits of Burosumab Therapy for X-Linked Hypophosphatemia (XLH) and Other Conditions in Adults and Children.

Authors:  Aaron Schindeler; Andrew Biggin; Craig F Munns
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-28       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.